Pathfinder Cell Therapy, Inc. PFND Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Pathfinder Cell Therapy, Inc. PFND Company Overview 

Stock Message Board http://investorshangout.com/search?q=PFND&...mp;yt1=Go!

Pathfinder Cell Therapy, Inc. PFND Current Price and Quotes
Last Price 0.0083
Previous Close 0.0083 Open N/A
Daily Range N/A - N/A 52wk Range 0.049 - 0.005
Volume 0 Dividend N/A
Average Vol (3m) 40,085 Yield N/A
Pathfinder Cell Therapy, Inc. PFND
Company Information

12 Bow Street
Cambridge, MA 02138

Website: http://www.synthemed.com
Phone: 617-245-0289
Email: info@SyntheMed.com

Pathfinder Cell Therapy, Inc. PFND
Pathfinder Cell Therapy, Inc. PFND
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000889428
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3842 - Surgical appliances and supplies
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Richard L. Franklin President, CEO, Secretary
John Benson CFO, Treasurer
Company Directors

Not Available
Company Notes

Formerly=SyntheMed, Inc. until 9-2011
Formerly=Life Medical Sciences, Inc. until 4-05
Service Providers

Auditor/Accountant
EisnerAmper LLP
750 Third Avenue
New York, NY, 10017
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Pathfinder Cell Therapy, Inc. PFND
PFND Security Details

Share Structure

Market Value1 $5,537,435 a/o Sep 06, 2013
Shares Outstanding 667,160,870 a/o Jun 30, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 323 a/o Apr 01, 2013
Short Selling Data

Short Interest 0 (-100%)
Jun 28, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

Pathfinder Cell Therapy, Inc. PFND Recent News

Pathfinder Cell Therapy, Inc. PFND Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 114 73 - 360
Cost of Revenue 50 26 - 164
Gross Profit 64 47 - 196
Operating Expenses

Research and Development 1,328 1,676 693 1,387
Sales, General and Admin. 796 1,989 134 2,929
Non-Recurring Items - 8,127 - -
Other - - - -
Operating Income (2,060) (11,745) (827) (4,120)
Income From Continuing Operations

Add'l Income/Expense Items - 583 (459) 20
Earnings Before Interest and Tax (2,060) (11,162) (1,286) (4,100)
Interest Expense 96 108 8 3
Earnings Before Tax (2,156) (11,270) (1,294) (4,103)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,156) (11,270) (1,294) (4,103)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,156) (11,270) (1,294) (4,103)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,156) (11,270) (1,294) (4,103)

PFND Pathfinder Cell Therapy, Inc. Research DD Guide

PFND Pathfinder Cell Therapy, Inc. Stock Message Board http://investorshangout.com/search?q=PFND&...mp;yt0=Go!
PFND Pathfinder Cell Therapy, Inc. Stock Quote http://www.otcmarkets.com/stock/PFND/quote
PFND Pathfinder Cell Therapy, Inc. Stock Chart http://www.otcmarkets.com/stock/PFND/chart
PFND Pathfinder Cell Therapy, Inc. Company Info http://www.otcmarkets.com/stock/PFND/company-info
PFND Pathfinder Cell Therapy, Inc. Recent News http://www.otcmarkets.com/stock/PFND/news
PFND Pathfinder Cell Therapy, Inc. Financials http://www.otcmarkets.com/stock/PFND/financials
PFND Pathfinder Cell Therapy, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/PFND/filings
PFND Pathfinder Cell Therapy, Inc. Short Sales http://www.otcmarkets.com/stock/PFND/short-sales
PFND Pathfinder Cell Therapy, Inc. Insider Disclosure http://www.otcmarkets.com/stock/PFND/insider-transactions
PFND Pathfinder Cell Therapy, Inc. Research Reports http://www.otcmarkets.com/stock/PFND/research
PFND Pathfinder Cell Therapy, Inc. Summary http://finance.yahoo.com/q?s=PFND
PFND Pathfinder Cell Therapy, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=PFND+Historical+Prices
PFND Pathfinder Cell Therapy, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=PFND
PFND Pathfinder Cell Therapy, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=PFND+Basic+Chart
PFND Pathfinder Cell Therapy, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PFND+Basic+Tech.+Analysis
PFND Pathfinder Cell Therapy, Inc. Headlines http://finance.yahoo.com/q/h?s=PFND+Headlines
PFND Pathfinder Cell Therapy, Inc. Press Releases http://finance.yahoo.com/q/p?s=PFND+Press+Releases
PFND Pathfinder Cell Therapy, Inc. Company Profile http://finance.yahoo.com/q/pr?s=PFND+Profile
PFND Pathfinder Cell Therapy, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=PFND+Key+Statistics
PFND Pathfinder Cell Therapy, Inc. Industry http://finance.yahoo.com/q/in?s=PFND+Industry
PFND Pathfinder Cell Therapy, Inc. Major Holders http://finance.yahoo.com/q/mh?s=PFND+Major+Holders
PFND Pathfinder Cell Therapy, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=PFND+Insider+Transactions
PFND Pathfinder Cell Therapy, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=PFND+Insider+Roster
PFND Pathfinder Cell Therapy, Inc. Income Statement http://finance.yahoo.com/q/is?s=PFND
PFND Pathfinder Cell Therapy, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=PFND
PFND Pathfinder Cell Therapy, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=PFND+Cash+Flow&annual
PFND Pathfinder Cell Therapy, Inc. Nasdaq http://www.nasdaq.com/symbol/PFND
PFND Pathfinder Cell Therapy, Inc. Market Watch http://www.marketwatch.com/investing/stock/PFND
PFND Pathfinder Cell Therapy, Inc. Bloomberg http://www.bloomberg.com/quote/PFND:US
PFND Pathfinder Cell Therapy, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=PFND
PFND Pathfinder Cell Therapy, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=PFND
PFND Pathfinder Cell Therapy, Inc. Barchart http://www.barchart.com/quotes/stocks/PFND
PFND Pathfinder Cell Therapy, Inc. OTC Short Report http://otcshortreport.com/index.php?index=PFND
PFND Pathfinder Cell Therapy, Inc. Investopedia http://www.investopedia.com/markets/stocks/PFND/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Bitcoin Depot Transitions to Streamlined Corporate Structure

Updated Category News Views 181

Bitcoin Depot Announces Simplified Corporate Structure Bitcoin Depot Inc. (Nasdaq: BTM), a significant player in the Bitcoin ATM realm and leading fintech company, has made a pivotal move by simplifying its corporate framework. This restructuring effort, known as the Up-C Restructuring, is aimed at enhancing operational efficiency and creating a straightforward capital...

Continue Reading
Innovative Solutions for Fibre Operators: Focus on ConnectMaster

Updated Category News Views 211

Discovering ConnectMaster™ for Fibre Operators VertiGIS, a pioneer in spatial asset management solutions, provides an innovative platform called ConnectMaster™. This comprehensive tool revolutionizes how fibre operators handle their network inventory management by integrating design, documentation, operations, and analytics into one seamless solution. Operating as a...

Continue Reading
Harnessing AI to Transform the Herbal Market Landscape

Updated Category News Views 188

Herbal Market Growth Forecast The herbal market is experiencing remarkable growth, with projections indicating an increase of USD 130.3 billion between 2024 and 2028. This significant expansion is largely driven by a rise in health issues, particularly liver and heart diseases, coupled with a growing awareness of the benefits of natural remedies. Statistical analyses...

Continue Reading
Strong Results Highlight EnLink Midstream's Q3 Performance

Updated Category News Views 25

EnLink Midstream Delivers Exceptional Third Quarter Results EnLink Midstream, LLC (NYSE: ENLC) recently reported its financial outcomes for the third quarter of 2024, showcasing a range of impressive results. This strong performance reflects the company’s effective execution of its strategic operations. Notable Financial Highlights During the third quarter, EnLink...

Continue Reading
Razor Energy Corp Completes Significant Transaction Amid Restructuring

Updated Category News Views 800

Overview of the Recent Transaction Razor Energy Corp, known for its innovative approach within the energy sector, has concluded a major transaction that is pivotal for its future. The Corporation, along with its subsidiaries, Blade Energy Services Corp. and Razor Holdings GP Corp., has finalized the sale transaction as per the Subscription Agreement with Texcal Energy...

Continue Reading